ClinicalTrials.Veeva

Menu

Gastroenteritis in Pediatric Population of Qatar (GE)

Hamad Medical Corporation (HMC) logo

Hamad Medical Corporation (HMC)

Status

Enrolling

Conditions

Gastroenteritis

Treatments

Diagnostic Test: Molecular method (PCR)

Study type

Observational

Funder types

Industry

Identifiers

NCT03046342
14-00045

Details and patient eligibility

About

Comparison of clinical and laboratory diagnosis for cause of Gastroenteritis(GE) depending on the clinical manifestation.Identifying the sources of viral, bacterial and parasitic GE in Pediatric population of Qatar

Full description

Processing of stool samples by molecular method (PCR) for children with GE including complete data collection. Patients are followed up for 14 days

Enrollment

3,000 estimated patients

Sex

All

Ages

3 months to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All acute gastroenteritis patients between 3 months to 14 years presenting to PEC centers with acute diarrhea+/- vomiting with or without fever

Exclusion criteria

  1. Cases of vomiting +/- fever only without diarrhea
  2. Suspicion of surgical abdomen
  3. Bile stained vomitus
  4. Mal-absorption diseases as cystic fibrosis, celiac disease or increased secretion as disaccharides deficiency
  5. Cases of Inflammatory bowel disease
  6. Antibiotic associated diarrhea
  7. Patients with immune deficiency
  8. Patients with chronic diarrhea (>2 weeks of diarrhea)
  9. Patients receiving long term medication for any disease

Trial contacts and locations

1

Loading...

Central trial contact

Dr.Khalid Alansari

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems